Company intelligence / Profile preview

MediSensor

San Jose, California, United Statesmedisensor.tech ↗

Ownership: Private
Development stage: Commercial

Overview

"MediSensor" offers an AI-driven smart pill organizer with automated reminders and provider integration to improve medication adherence. No clinical trial data is referenced but claims >50% improvement in regimen optimization. "C8 MediSensors" developed a noninvasive continuous glucose monitor using Raman spectroscopy; raised $24 million in funding with plans to launch in Europe pending CE Mark approval circa 2012. No recent updates on commercial status.

Therapeutic areas: OtherEndocrinology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

GE Healthcare invested significantly in C8 MediSensors through its healthymagination Fund.

Beyond the preview

Go deeper on MediSensor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MediSensor.

Explore the full profile